Annual Operating Profit
-$15.10 M
+$26.96 M+64.10%
December 31, 2023
Summary
- As of February 7, 2025, AQST annual operating income is -$15.10 million, with the most recent change of +$26.96 million (+64.10%) on December 31, 2023.
- During the last 3 years, AQST annual operating profit has risen by +$27.79 million (+64.79%).
- AQST annual operating profit is now -13264.60% below its all-time high of -$113.00 thousand, reached on December 31, 2017.
Performance
AQST Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$8.29 M
-$8.35 M-15172.73%
September 30, 2024
Summary
- As of February 7, 2025, AQST quarterly operating income is -$8.29 million, with the most recent change of -$8.35 million (-15172.73%) on September 30, 2024.
- Over the past year, AQST quarterly operating profit has dropped by -$5.91 million (-248.76%).
- AQST quarterly operating profit is now -179.55% below its all-time high of $10.42 million, reached on September 30, 2017.
Performance
AQST Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$21.10 M
-$5.91 M-38.93%
September 30, 2024
Summary
- As of February 7, 2025, AQST TTM operating income is -$21.10 million, with the most recent change of -$5.91 million (-38.93%) on September 30, 2024.
- Over the past year, AQST TTM operating profit has increased by +$801.00 thousand (+3.66%).
- AQST TTM operating profit is now -395.44% below its all-time high of $7.14 million, reached on September 30, 2017.
Performance
AQST TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
AQST Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +64.1% | -248.8% | +3.7% |
| 3 y3 years | +64.8% | -248.8% | +3.7% |
| 5 y5 years | +69.1% | -248.8% | +3.7% |
AQST Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +64.1% | <-9999.0% | +35.0% | -39.7% | +51.0% |
| 5 y | 5-year | at high | +71.3% | -2198.7% | +47.0% | -39.7% | +60.5% |
| alltime | all time | <-9999.0% | +71.3% | -179.6% | +74.7% | -395.4% | +68.7% |
Aquestive Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.29 M(<-9900.0%) | -$21.10 M(+38.9%) |
| Jun 2024 | - | $55.00 K(-100.6%) | -$15.19 M(-21.9%) |
| Mar 2024 | - | -$8.96 M(+129.0%) | -$19.45 M(+28.8%) |
| Dec 2023 | -$15.10 M(-64.1%) | -$3.91 M(+64.5%) | -$15.10 M(-31.1%) |
| Sep 2023 | - | -$2.38 M(-43.5%) | -$21.90 M(-22.8%) |
| Jun 2023 | - | -$4.21 M(-8.6%) | -$28.38 M(-23.2%) |
| Mar 2023 | - | -$4.61 M(-57.0%) | -$36.93 M(-12.2%) |
| Dec 2022 | -$42.07 M(+21.3%) | -$10.71 M(+21.0%) | -$42.07 M(-2.2%) |
| Sep 2022 | - | -$8.85 M(-30.6%) | -$43.02 M(+2.1%) |
| Jun 2022 | - | -$12.76 M(+31.1%) | -$42.14 M(+17.4%) |
| Mar 2022 | - | -$9.74 M(-16.5%) | -$35.89 M(+3.5%) |
| Dec 2021 | -$34.68 M(-19.1%) | -$11.67 M(+46.4%) | -$34.68 M(-10.3%) |
| Sep 2021 | - | -$7.97 M(+22.3%) | -$38.66 M(-13.1%) |
| Jun 2021 | - | -$6.52 M(-23.6%) | -$44.47 M(+18.4%) |
| Mar 2021 | - | -$8.53 M(-45.5%) | -$37.56 M(-12.4%) |
| Dec 2020 | -$42.89 M | -$15.65 M(+13.5%) | -$42.89 M(+15.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$13.78 M(-3588.9%) | -$37.15 M(+8.1%) |
| Jun 2020 | - | $395.00 K(-102.8%) | -$34.37 M(-35.7%) |
| Mar 2020 | - | -$13.86 M(+40.0%) | -$53.45 M(+1.5%) |
| Dec 2019 | -$52.67 M(+7.6%) | -$9.90 M(-10.0%) | -$52.67 M(-4.4%) |
| Sep 2019 | - | -$11.00 M(-41.1%) | -$55.12 M(+3.4%) |
| Jun 2019 | - | -$18.69 M(+42.9%) | -$53.32 M(-20.8%) |
| Mar 2019 | - | -$13.07 M(+5.8%) | -$67.34 M(+37.5%) |
| Dec 2018 | -$48.94 M(>+9900.0%) | -$12.36 M(+34.2%) | -$48.96 M(+11.6%) |
| Sep 2018 | - | -$9.21 M(-71.9%) | -$43.86 M(+81.0%) |
| Jun 2018 | - | -$32.71 M(-716.5%) | -$24.24 M(-649.5%) |
| Mar 2018 | - | $5.30 M(-173.1%) | $4.41 M(-4003.5%) |
| Dec 2017 | -$113.00 K(-86.7%) | -$7.26 M(-169.6%) | -$113.00 K(-101.6%) |
| Sep 2017 | - | $10.42 M(-356.7%) | $7.14 M(-317.9%) |
| Jun 2017 | - | -$4.06 M(-619.7%) | -$3.28 M(-519.7%) |
| Mar 2017 | - | $781.00 K | $781.00 K |
| Dec 2016 | -$847.00 K | - | - |
FAQ
- What is Aquestive Therapeutics annual operating income?
- What is the all time high annual operating profit for Aquestive Therapeutics?
- What is Aquestive Therapeutics annual operating profit year-on-year change?
- What is Aquestive Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Aquestive Therapeutics?
- What is Aquestive Therapeutics quarterly operating profit year-on-year change?
- What is Aquestive Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Aquestive Therapeutics?
- What is Aquestive Therapeutics TTM operating profit year-on-year change?
What is Aquestive Therapeutics annual operating income?
The current annual operating profit of AQST is -$15.10 M
What is the all time high annual operating profit for Aquestive Therapeutics?
Aquestive Therapeutics all-time high annual operating income is -$113.00 K
What is Aquestive Therapeutics annual operating profit year-on-year change?
Over the past year, AQST annual operating income has changed by +$26.96 M (+64.10%)
What is Aquestive Therapeutics quarterly operating income?
The current quarterly operating profit of AQST is -$8.29 M
What is the all time high quarterly operating profit for Aquestive Therapeutics?
Aquestive Therapeutics all-time high quarterly operating income is $10.42 M
What is Aquestive Therapeutics quarterly operating profit year-on-year change?
Over the past year, AQST quarterly operating income has changed by -$5.91 M (-248.76%)
What is Aquestive Therapeutics TTM operating income?
The current TTM operating profit of AQST is -$21.10 M
What is the all time high TTM operating profit for Aquestive Therapeutics?
Aquestive Therapeutics all-time high TTM operating income is $7.14 M
What is Aquestive Therapeutics TTM operating profit year-on-year change?
Over the past year, AQST TTM operating income has changed by +$801.00 K (+3.66%)